Peer-reviewed medical journal
Appears in 4 stories · Last updated Nov 5, 2026
Published the peer-reviewed trial report
Three adults with epilepsy that drugs could not control agreed to have viruses infused into a small patch of their brains. Their monthly seizures fell by a mean of 92.6%, according to results published in the New England Journal of Medicine.
Updated 6 days ago
Publisher of the TRIUMPH-1 results
Eli Lilly's obesity drug retatrutide met its goals in two late-stage trials published in late September. The 12 mg dose produced 30.3% average weight loss over 104 weeks in adults with obesity, per Lilly's topline (the NEJM paper's primary 80-week endpoint was 25.0%), a level once seen mainly after bariatric surgery. In 1,152 adults with type 2 diabetes, the same dose cut weight 18.8% at 80 weeks, and 79% reached an HbA1c of 6.5% or lower.
Updated Oct 18
Publisher of ARISE FLUIDS and the earlier trials in this arc
Septic shock treatment rests on a simple rule: give fluids fast and plenty of them. A trial in the New England Journal of Medicine tested the opposite strategy — less fluid, earlier vasopressors — and found patients did just as well.
Updated Oct 17
As of September 2026: Published the ALTNV study
Nearly one in ten patients with tick-bite fevers in a new Chinese study carried a virus that had never been seen before. Researchers named it Asian longhorned tick nairovirus (ALTNV), after the tick species that spreads it, and reported the finding in the New England Journal of Medicine.
Updated Sep 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
